Clinical Trials Directory

Trials / Completed

CompletedNCT02878213

DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
EPD Solutions, A Philips Company · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate real-time gap detection using EPD D700 dielectric sensing compared with customary electrical isolation tests and Adenosine infusion at the end of the procedure. Furthermore, safety, usability and clinical applicability of the system for guided AF ablation will be confirmed.

Detailed description

Prospective, single-center, non-randomized, non-blinded, open label, and single arm study. All procedures will be performed under CARTO-3 guidance for the treatment of atrial fibrillation (AF). The EPD D700 system will be used in-tandem, to record pre-, during and immediate post-ablation tissue characteristics and compute likelihood of lesion transmurality and permanency. Additionally, D700 system safety, feasibility, usability and clinical applicability will be documented. The entire procedure will be conducted as customary, using standard and approved off-the-shelf equipment (body surface electrodes, diagnostic and irrigated ablation catheters, RF generator and recording system), in a completely clinically independent manner from the EPD D700 system. The physician will neither use nor rely on any of the D700 system output for clinical decision making and will be blinded to the D700 lesion assessment forecasts. After 30 days following the initial procedure, a repeated procedure will be performed for gap detection and its results will be correlated with the D700 predictions.

Conditions

Interventions

TypeNameDescription
DEVICED700 SystemAtrial Fibrillation Ablation Procedure

Timeline

Start date
2016-09-23
Primary completion
2017-01-25
Completion
2017-11-16
First posted
2016-08-25
Last updated
2019-11-18
Results posted
2019-11-18

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT02878213. Inclusion in this directory is not an endorsement.